AAAAAA
Results:
1-23
|
Results: 23
Authors:
de The, H
Chelbi-Alix, MK
Citation: H. De The et Mk. Chelbi-alix, APL, a model disease for cancer therapies?, ONCOGENE, 20(49), 2001, pp. 7136-7139
Authors:
Zhu, J
Lallemand-Breitenbach, V
de The, H
Citation: J. Zhu et al., Pathways of retinoic acid- or arsenic trioxide-induced PML/RAR alpha catabolism, role of oncogene degradation in disease remission, ONCOGENE, 20(49), 2001, pp. 7257-7265
Authors:
Lallemand-Breitenbach, V
Zhu, J
de The, H
Citation: V. Lallemand-breitenbach et al., Promyelocytic leukemia, a unique model to design treatments targeting oncogenes, M S-MED SCI, 17(1), 2001, pp. 14-22
Authors:
Regad, T
Saib, A
Lallemand-Breitenbach, V
Pandolfi, PP
de The, H
Chelbi-Alix, MK
Citation: T. Regad et al., PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator, EMBO J, 20(13), 2001, pp. 3495-3505
Authors:
Bertheau, P
Plassa, LF
Lerebours, F
de Roquancourt, A
Turpin, E
Lidereau, R
de The, H
Janin, A
Citation: P. Bertheau et al., Allelic loss detection in inflammatory breast cancer: Improvement with laser microdissection, LAB INV, 81(10), 2001, pp. 1397-1402
Authors:
Tobaly-Tapiero, J
Bittoun, P
Giron, ML
Neves, M
Koken, M
Saib, A
de The, H
Citation: J. Tobaly-tapiero et al., Human foamy virus capsid formation requires an interaction domain in the Nterminus of Gag, J VIROLOGY, 75(9), 2001, pp. 4367-4375
Authors:
Lallemand-Breitenbach, V
Zhu, J
Puvion, F
Koken, M
Honore, N
Doubeikovsky, A
Duprez, E
Pandolfi, PP
Puvion, E
Freemont, P
de The, H
Citation: V. Lallemand-breitenbach et al., Role of promyelocytic leukemia (PML) sumolation in nuclear body formation,11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation, J EXP MED, 193(12), 2001, pp. 1361-1371
Authors:
Bertheau, P
Rivet, J
de Roquancourt, A
de The, H
Espie, M
Janin, A
Citation: P. Bertheau et al., Microdissection and breast cancer, J MOL MED-J, 78(7), 2000, pp. B31-B31
Authors:
Bazarbachi, A
Nasr, R
El-Sabban, ME
Mahe, A
Mahieux, R
Gessain, A
Darwiche, N
Dbaibo, G
Kersual, J
Zermati, Y
Dianoux, L
Chelbi-Alix, MK
de The, H
Hermine, O
Citation: A. Bazarbachi et al., Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma, LEUKEMIA, 14(4), 2000, pp. 716-721
Authors:
Kopf, E
Plassat, JL
Vivat, V
de The, H
Chambon, P
Rochette-Egly, C
Citation: E. Kopf et al., Dimerization with retinoid x receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway, J BIOL CHEM, 275(43), 2000, pp. 33280-33288
Authors:
El-Sabban, ME
Nasr, R
Dbaibo, G
Hermine, O
Abboushi, N
Quignon, F
Ameisen, JC
Bex, F
de The, H
Bazarbachi, A
Citation: Me. El-sabban et al., Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-kappa B activation, BLOOD, 96(8), 2000, pp. 2749-2755
Authors:
El-Sabban, ME
Nasr, R
Dbaibo, G
Hermine, O
Abboushi, N
Quignon, F
Ameisen, JC
Bex, F
de The, H
Bazarbachi, A
Citation: Me. El-sabban et al., Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-kappa B activation, BLOOD, 96(8), 2000, pp. 2849-2855
Authors:
Kroemer, G
de The, H
Citation: G. Kroemer et H. De The, Arsenic trioxide, a novel mitochondriotoxic anticancer agent?, J NAT CANC, 91(9), 1999, pp. 743-745
Authors:
Turpin, E
Dalle, B
de Roquancourt, A
Plassa, LF
Marty, M
Janin, A
Beuzard, Y
de The, H
Citation: E. Turpin et al., Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers, ONCOGENE, 18(54), 1999, pp. 7834-7837
Authors:
Venturini, L
You, J
Stadler, M
Galien, R
Lallemand, VR
Koken, MHM
Mattei, MG
Ganser, A
Chambon, P
Losson, R
de The, H
Citation: L. Venturini et al., TIF1 gamma, a novel member of the transcriptional intermediary factor 1 family, ONCOGENE, 18(5), 1999, pp. 1209-1217
Authors:
Chelbi-Alix, MK
de The, H
Citation: Mk. Chelbi-alix et H. De The, Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins, ONCOGENE, 18(4), 1999, pp. 935-941
Authors:
Koken, MHM
Daniel, MT
Gianni, M
Zelent, A
Licht, J
Buzyn, A
Minard, P
Degos, L
Varet, B
de The, H
Citation: Mhm. Koken et al., Retinoic acid, but not arsenic trioxide, degrades the PLZF/RAR alpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient, ONCOGENE, 18(4), 1999, pp. 1113-1118
Authors:
Gianni, M
de The, H
Citation: M. Gianni et H. De The, In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies, LEUKEMIA, 13(5), 1999, pp. 739-749
Authors:
Puvion-Dutilleul, F
Legrand, V
Mehtali, M
Chelbi-Alix, MK
de The, H
Puvion, E
Citation: F. Puvion-dutilleul et al., Deletion of the fiber gene induces the storage of hexon and penton base proteins in PML/Sp100-containing inclusions during adenovirus infection, BIO CELL, 91(8), 1999, pp. 617-628
Authors:
Zhu, J
Gianni, M
Kopf, E
Honore, N
Chelbi-Alix, M
Koken, M
Quignon, F
Rochette-Egly, C
de The, H
Citation: J. Zhu et al., Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins, P NAS US, 96(26), 1999, pp. 14807-14812
Authors:
Lallemand-Breitenbach, V
Guillemin, MC
Janin, A
Daniel, MT
Degos, L
Kogan, SC
Bishop, JM
de The, H
Citation: V. Lallemand-breitenbach et al., Retinoic acid and arsenic synergize to eradicate leukemic cells in a mousemodel of acute promyelocytic leukemia, J EXP MED, 189(7), 1999, pp. 1043-1052
Authors:
Duprez, E
Saurin, AJ
Desterro, JM
Lallemand-Breitenbach, V
Howe, K
Boddy, MN
Solomon, E
de The, H
Hay, RT
Freemont, PS
Citation: E. Duprez et al., SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation, J CELL SCI, 112(3), 1999, pp. 381-393
Authors:
Bazarbachi, A
El-Sabban, ME
Nasr, R
Quignon, F
Awaraji, C
Kersual, J
Dianoux, L
Zermati, Y
Haidar, JH
Hermine, O
de The, H
Citation: A. Bazarbachi et al., Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells, BLOOD, 93(1), 1999, pp. 278-283
Risultati:
1-23
|